NEW YORK , Aug. 22, 2024 /PRNewswire/ -- The global sleep apnea diagnostic and therapeutic devices market size is estimated to grow by USD 3.90 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of almost 9.45% during the forecast period. Increasing prevalence of sleep apnea disorders is driving market growth, with a trend towards technological advances in sleep apnea devices.
However, high cost of sleep apnea devices poses a challenge. Key market players include APEX Medical Corp., Asahi Kasei Corp.
, BMC MEDICAL CO. LTD., Braebon Medical Corp.
, Cadwell Industries Inc., Circadiance LLC, Cleveland Medical Devices Inc., Compumedics Ltd.
, DeVilbiss Healthcare GmbH, Fisher and Paykel Healthcare Corp. Ltd., Koninklijke Philips N.
V., Lowenstein Medical Technology GmbH and Co. KG, Mallinckrodt Plc, Natus Medical Inc.
, Nihon Kohden Corp., React Health, ResMed Inc., Sefam, SOMNOmedics GmbH, and Teleflex Inc.
. Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report Market Driver The sleep apnea diagnostic and therapeutic devices market is experiencing significant growth due to technological advancements in sleep apnea technology. Vendors are investing heavily in research and development to create reliable and effective tools for diagnosing sleep apnea disorders and providing accurate diagnoses with improved patient care.
These advances include wearable sleep apnea devices, lightweigh.